Showing results (1101-1110 of 1,170) with videos related to

Sort By:
Pageof 117
The European Respiratory Journal|August 26, 2022
Association of respiratory symptoms and lung function with occupation in the multinational Burden of Obstructive Lung Disease (BOLD) studyJate Ratanachina, Andre F S Amaral, Sara De Matteis, et al.
Respiratory Research|May 24, 2023
The association of spirometric small airways obstruction with respiratory symptoms, cardiometabolic diseases, and quality of life: results from the Burden of Obstructive Lung Disease (BOLD) studyBen Knox-Brown, Jaymini Patel, James Potts, et al.
Cell Stem Cell|August 5, 2022
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasiaEster Gil Vasquez, Nadia Nasreddin, Gabriel N Valbuena, et al.
Melanoma Research|June 15, 2022
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitorsRawa K Ismail, Karijn P M Suijkerbuijk, Anthonius de Boer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 21, 2021
Nationwide oncological networks for resection of colorectal liver metastases in the Netherlands: Differences and postoperative outcomesArthur K E Elfrink, Niels F M Kok, Rutger-Jan Swijnenburg, et al.
Cancers|July 2, 2021
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint InhibitorsNienke A de Glas, Esther Bastiaannet, Frederiek van den Bos, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2020
Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registryM C T van Zeijl, L C de Wreede, A J M van den Eertwegh, et al.
International Journal of Cancer|June 26, 2024
Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide studyManja Bloem, Olivier J van Not, Maureen J B Aarts, et al.
Eclinicalmedicine|February 19, 2024
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021Olivier J van Not, Alfons J M van den Eertwegh, John B Haanen, et al.
JAMA Oncology|October 27, 2022
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced MelanomaOlivier J van Not, Rik J Verheijden, Alfonsus J M van den Eertwegh, et al.
Pageof 117